In 2005, David Lyden saw something startling. He and his associates at Weill Cornell Medical College had been exploring metastasis—the spread of tumor starting with one a player in the body then onto the next. The group had demonstrated that bone marrow–derived cells (BMDCs) were enlisted to future metastatic locales before...
